Optibrium Announce the Release of StarDrop™ 6.6

/in , /by

Novel features include a unique pKa model, combining quantum mechanics and machine learning methods, and extended capabilities in structure-based design CAMBRIDGE, UK – Optibrium™, a developer of software for drug discovery, today announced the introduction of StarDrop™ 6.6, the latest version of this comprehensive software platform for small molecule design, optimisation and data analysis. The enhanced […]

Read more →

Optibrium introduces Augmented Chemistry™ services to guide successful drug discovery

/in , /by

CAMBRIDGE, UK, 10 October, 2019 – Optibrium™, a developer of software for drug discovery, today announced the introduction of its Augmented Chemistry™ services, which provide collaborators with novel artificial intelligence technologies to supplement their skills and experience, enabling them to make more effective decisions and advance their drug discovery projects. In discovery projects, it is important […]

Read more →

Schrödinger Announces Collaboration with AstraZeneca to Deploy Advanced Computing Technology for Drug Discovery

/in /by

NEW YORK – Schrödinger today announced a collaboration with AstraZeneca to deploy Schrödinger’s advanced computing platform to help accelerate drug discovery efforts. Schrödinger’s computational platform combines physics-based modeling and machine learning to enable chemists to predict the potency of a molecule binding to a target protein. This increases the likelihood that, when synthesized, compounds will have […]

Read more →

Schrödinger and Qu & Co Announce Collaboration to Advance Quantum Mechanical Computations on Quantum Computers

/in , /by

NEW YORK and AMSTERDAM – Schrödinger and Qu & Co today announced a business and scientific collaboration to advance the use of quantum mechanics on complex molecular systems using quantum computing hardware. Quantum mechanical simulations have become a powerful tool to accelerate materials science and design, but executing the same computations on quantum computers so far […]

Read more →

ChemAxon and Research Space joint announcement of integrated assay data upload prototype

/in , /by

ChemAxon and Research Space are pleased to announce the development of a prototype for direct assay data upload from RSpace ELN to ChemAxon Assay. RSpace is an electronic lab notebook used to collect, organize and present life sciences research data, and is distinguished by its flexibility in supporting a variety of workflows, strong support for traceability, and […]

Read more →

Voronoi selects CDD Vault platform to manage its Drug Discovery Data

/in , , /by

CDD Vault will support Voronoi’s collaborative research on Kinase Inhibitor and TPD INCHEON, South Korea and SAN FRANCISCO, Aug. 23, 2019 /PRNewswire/ — Voronoi, a drug discovery and development biotech company in Korea announced today that it has, after an extensive evaluation process, selected CDD Vault as its platform of choice to manage its drug discovery data and collaborative projects. […]

Read more →

Schrödinger Expands Drug Discovery Partnership with Morphic Therapeutic

/in , /by

Extended collaboration leveraging Schrödinger’s computational platform includes new terms with increased and additional milestone payments to Schrödinger NEW YORK – Schrödinger today announced an expansion of its computational design collaboration with Morphic Therapeutic (“Morphic”), a biotechnology company focused on developing a new class of oral small-molecule integrin-targeted therapeutics that Schrödinger co-founded with Harvard Professor Timothy Springer, […]

Read more →

Schrödinger Appoints Veteran Pharma Financial Leader Gary Sender to Board of Directors

/in , /by

NEW YORK – Schrödinger today announced the appointment of veteran pharmaceutical executive Gary Sender to its Board of Directors, as well as his appointment as Chair of the Audit Committee. Mr. Sender brings over 30 years of financial leadership experience, with a strong track record of success. “Gary’s business and finance expertise across entrepreneurial startups and […]

Read more →

Schrödinger Receives Milestone Payment from Ono as Collaborative Program Advances

/in , /by

NEW YORK – Schrödinger today announced receipt of a milestone payment from Ono Pharmaceutical Co., Ltd.(“Ono”) as part of a collaboration leveraging Schrödinger’s advanced computational platform to develop novel therapeutic candidates acting on the therapeutic target selected by Ono. To advance the program, Schrödinger deployed its reaction-based enumeration tools and machine-learning technologies to identify and filter millions […]

Read more →